CSIRO partners with Cicada to translate ‘superbug’ research
17 November 2021
The national science agency has partnered with a deep tech incubator to try and build out a local industry for antimicrobial resistance products, warning the pipeline for new “superbug” treatments is running dry.
CSIRO and Sydney deep tech incubator Cicada Innovations will offer local SMEs and researchers free training to commercialise their work into solutions for antimicrobial resistance (AMR), the emerging global public health threat where disease causing germs stop responding to medicine.
Further reading: CSIRO
Author(s): Joseph Brookes
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!